GLP-1 RA Induces Gut T-Cell and Epithelial Remodeling in PWH From a Clinical Trial in South Africa

Conference Reports for NATAP

Conference on Retroviruses
and Opportunistic Infections
Denver, CO 80202, United States
February 22 - 25, 2026


GLP-1 RA Induces Gut T-Cell and Epithelial Remodeling in PWH From a Clinical Trial in South Africa

	Miguel Marin Africa Health Research Institute, Durban, South Africa webcast: https://www.croiwebcasts.org/console/player/55037?mediaType=slideVideo& GLP at CROI GLP-1 Receptor Agonists: Are They a Cure for Everything? - Todd Brown Review (03/10/26) webcast: https://www.croiwebcasts.org/console/player/55088?mediaType=slideVideo& Initiating Semaglutide Therapy Reduces Tobacco Cigarette use among People with HIV - (03/07/26) Tirzepatide use in People with HIV Shows Effectiveness for Weight Loss and Diabetic Control - (03/07/26) Real-World Outcomes of Tirzepatide Use in People With HIV With and Without Diabetes - (03/07/26) Evaluation of GLP-1 Medications in an Observational Cohort of People with HIV in Washington, DC (2011-2025) - (03/07/26) Effects of Semaglutide on Subclinical Cardiovascular Health in People With HIV - (03/07/26) The Impact of Semaglutide on Depressive Symptoms Among People With HIV - (02/27/26) Longitudinal Associations of Semaglutide with Liver Fibrosis Score in People with HIV - (03/11/26)